ResearcherChinese Academy of SciencesNo recent work listed

Pengyu Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4475-2381; OpenAlex author ID A5100317565. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2022: 1 paper

Papers 1

Aberrant human ClpP activation disturbs mitochondrial proteome homeostasis to suppress pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.chembiol.2022.07.002 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Cai‐Guang Yang · 1 shared paper, 2022 · strength 0.13
- Paper Aberrant human ClpP activation disturbs mitochondrial proteome homeostasis to suppress pancreatic ductal adenocarcinoma. DOI 10.1016/j.chembiol.2022.07.002 ↗
Xiongxiong Lu · 1 shared paper, 2022 · strength 0.13
- Paper Aberrant human ClpP activation disturbs mitochondrial proteome homeostasis to suppress pancreatic ductal adenocarcinoma. DOI 10.1016/j.chembiol.2022.07.002 ↗
Lu Zhou · 1 shared paper, 2022 · strength 0.13
- Paper Aberrant human ClpP activation disturbs mitochondrial proteome homeostasis to suppress pancreatic ductal adenocarcinoma. DOI 10.1016/j.chembiol.2022.07.002 ↗
Yonghui Zhang · 1 shared paper, 2022 · strength 0.13
- Paper Aberrant human ClpP activation disturbs mitochondrial proteome homeostasis to suppress pancreatic ductal adenocarcinoma. DOI 10.1016/j.chembiol.2022.07.002 ↗
Xinjing Wang · 1 shared paper, 2022 · strength 0.13
- Paper Aberrant human ClpP activation disturbs mitochondrial proteome homeostasis to suppress pancreatic ductal adenocarcinoma. DOI 10.1016/j.chembiol.2022.07.002 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.